Lifeward (LFWD) Stock Price, News & Analysis

Company Overview

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.

Key Stats

• Today's Range: $7.03 to $7.33
• 50-Day Range: $6.99 to $8.73
• 52-Week Range: $4.14 to $10.56
• Volume: 4,242 shs
• Average Volume: 6,496 shs
• Market Capitalization: $20.09 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $10.00
• Consensus Rating: Hold

Lifeward Stock Analysis - MarketRank™

Lifeward scored higher than 46% of companies evaluated by MarketBeat, and ranked 631st out of 913 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.9 / 5
• Analyst Rating: Hold

Consensus Rating

Lifeward has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and 1 sell rating.

Upside Potential

Lifeward has a consensus price target of $10.00, representing about 40.8% upside from its current price of $7.10.

Amount of Analyst Coverage

Lifeward has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: Decreasing

Earnings Growth

Earnings for Lifeward are expected to decrease in the coming year, from ($0.44) to ($1.84) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Lifeward is -0.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Lifeward is -0.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Lifeward has a P/B Ratio of 1.65. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

4.34% of the float of Lifeward has been sold short.

Short Interest Ratio / Days to Cover

Lifeward has a short interest ratio ("days to cover") of 17.83, which indicates bearish sentiment.

Change versus previous month

Short interest in Lifeward has recently decreased by 0.50%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Lifeward does not currently pay a dividend.

Dividend Growth

Lifeward does not have a long track record of dividend growth.

News and Social Media

• Score: 3.2 / 5
• News Sentiment: 0.10

News Sentiment

Lifeward has a news sentiment score of 0.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.78 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for Lifeward this week, compared to 2 articles on an average week.

Search Interest

3 people have searched for LFWD on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.

MarketBeat Follows

1 people have added Lifeward to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Lifeward insiders have not sold or bought any company stock.

Percentage Held by Insiders

1.50% of the stock of Lifeward is held by insiders.

Percentage Held by Institutions

26.76% of the stock of Lifeward is held by institutions.

Company Calendar

• Last Earnings: 8/15/2026
• Today: 9/03/2026
• Next Earnings (Estimated): 11/13/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:LFWD
• Previous Symbol: NASDAQ:LFWD
• CIK: 1607962
• Web: www.rewalk.com
• Phone: 972-4-959-0123
• Fax: N/A
• Employees: 60
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Lifeward: $10.00
• High Price Target: $10.00
• Low Price Target: $10.00
• Potential Upside/Downside: +40.8%
• Consensus Rating: Hold
• Rating Score (0-4): 2.25
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): ($16.82)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$19.91 million
• Net Margins: -141.28%
• Pretax Margin: -141.51%
• Return on Equity: -235.86%
• Return on Assets: -81.72%

Debt

• Debt-to-Equity Ratio: 0.70
• Current Ratio: 2.33
• Quick Ratio: 1.77

Sales & Book Value

• Annual Sales: $22.03 million
• Price / Sales: 0.91
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $4.31 per share
• Price / Book: 1.65

Miscellaneous

• Outstanding Shares: 2,830,000
• Free Float: 2,790,000
• Market Cap: $20.09 million
• Optionable: Optionable
• Beta: 0.39